NCT04138615View on ClinicalTrials.gov

Analgesics in the Pre-hospital Setting: Implications on Hemorrhage Tolerance - Morphine

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

November 12, 2019

Primary Completion Date

January 4, 2022

Study Completion Date

January 4, 2022

Conditions
Healthy
Interventions
DRUG

Morphine

Subjects will receive Morphine while the effects of this drug on tolerance to a hemorrhagic insult will be assessed.

OTHER

Placebo

Subjects will receive saline while the effects of this drug on tolerance to a hemorrhagic insult will be assessed.

Trial Locations (1)

75390

University of Texas Southwestern Medical Center, Dallas

All Listed Sponsors
lead

University of Texas Southwestern Medical Center

OTHER

NCT04138615 - Analgesics in the Pre-hospital Setting: Implications on Hemorrhage Tolerance - Morphine | Biotech Hunter | Biotech Hunter